Back to the list
Congress: ECR26
Poster Number: C-12767
Type: Poster: EPOS Radiologist (educational)
Authorblock: J. Miguez Gonzalez, R. Oliveira Caiafa, P. Lozano Arranz, L. Pelegri Martinez, F. Calaf Forn, M. Valls Mellado, A. M. Herrera Pulido, L. I. Sarati Nieto, C. Pallàs Guardiola; Barcelona/ES
Disclosures:
Javier Miguez Gonzalez: Nothing to disclose
Rafael Oliveira Caiafa: Nothing to disclose
Pilar Lozano Arranz: Nothing to disclose
Laura Pelegri Martinez: Nothing to disclose
Francesc Calaf Forn: Nothing to disclose
Marc Valls Mellado: Nothing to disclose
Angélica María Herrera Pulido: Nothing to disclose
Lorena Ivonne Sarati Nieto: Nothing to disclose
Cristina Pallàs Guardiola: Nothing to disclose
Keywords: Interventional non-vascular, Oncology, Peritoneum, CT, Ultrasound, Biopsy, Cancer, Metastases, Multidisciplinary cancer care
Conclusion

US-guided omental biopsy is a feasible, safe and cost-effective procedure for histological diagnosis in patients with peritoneal carcinomatosis of unknown origin that present omental involvement on CT. Therefore, we believe it should be considered a standard of care in dedicated oncological centres.

Fig 11: Summary of the main advantages of US-guided omental biopsy.

 

GALLERY